Kevin currently serves as Alliance Director in R&D External Innovation at Novo Nordisk, where he develops and leads strategic collaborations with biotechnology companies and academic institutions globally. His portfolio spans early co-discovery through late-stage clinical programs, with responsibilities ranging from opportunity identification and partnership development, through program management and joint governance.

He has previously held roles as Chief Scientific Officer of cancer diagnostics-developper 3D Signatures, was founding Chief Executive of Concordia University’s PERFORM Centre in preventive health, and led the New Zealand government's foreign investment attraction efforts in life sciences.

Kevin serves on the Advisory Council of the Association of Strategic Alliance Professionals, and contributes to the development of ISO international standards for collaborative business relationships. He continues to support Canadian efforts focused on human research standards, health innovation and economic development.

He holds a BSc in Biology from the University of Victoria, and a PhD in Experimental Medicine from McGill University working in fundamental DNA repair at the Institut du cancer de Montreal and Procrea Biosciences. He completed his postdoctoral fellowship in translational neuroscience, gene therapy, and peptide vaccines at the University of Auckland.